NMR structure-based drug design

SummaryNMR is a useful tool for rapidly determining the conformations of receptor-bound ligands and identifying those protions of the ligand in contact with the receptor. In addition, the complete 3D structures of receptors and ligand/receptor complexes can be obtained using recently developed heteronuclear multi-dimensional NMR techniques. This NMR-derived structural information is potentially useful for aiding in the design of improved pharmaceutical agents. Approaches for utilizing the NMR-derived structural information along with the computational tools that facilitate this process are discussed.

[1]  Ad Bax,et al.  Three-dimensional heteronuclear NMR of nitrogen-15 labeled proteins , 1989 .

[2]  A. Petros,et al.  Identification of solvent-exposed regions of an FK-506 analog, ascomycin, bound to FKBP using a paramagnetic probe , 1992, Journal of biomolecular NMR.

[3]  Owen Johnson,et al.  The development of versions 3 and 4 of the Cambridge Structural Database System , 1991, J. Chem. Inf. Comput. Sci..

[4]  S E Ealick,et al.  Application of crystallographic and modeling methods in the design of purine nucleoside phosphorylase inhibitors. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Montelione,et al.  Accurate measurements of long-range heteronuclear coupling constants from homonuclear 2D NMR spectra of isotope-enriched proteins , 1989 .

[6]  D. Norbeck,et al.  Design, activity, and 2.8 A crystal structure of a C2 symmetric inhibitor complexed to HIV-1 protease. , 1990, Science.

[7]  S. Fesik,et al.  Heteronuclear three-dimensional nmr spectroscopy. A strategy for the simplification of homonuclear two-dimensional NMR spectra , 1988 .

[8]  I. Kuntz.  Structure-Based Strategies for Drug Design and Discovery , 1992, Science.

[9]  Kurt Wüthrich,et al.  Determination of scalar coupling constants by inverse Fourier transformation of in-phase multiplets , 1992 .

[10]  Osman F. Güner,et al.  Use of flexible queries for searching conformationally flexible molecules in databases of three-dimensional structures , 1992, J. Chem. Inf. Comput. Sci..

[11]  I. Kuntz,et al.  Automated docking with grid‐based energy evaluation , 1992 .

[12]  Andrew Smellie,et al.  Fast drug-receptor mapping by site-directed distances: a novel method of predicting new pharmacological leads , 1991, J. Chem. Inf. Comput. Sci..

[13]  S. Freer,et al.  Design of enzyme inhibitors using iterative protein crystallographic analysis. , 1991, Journal of medicinal chemistry.

[14]  C A Morse,et al.  Crystal-structure-based design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthase. , 1992, Journal of medicinal chemistry.

[15]  L. Kay,et al.  New methods for the measurement of NHCαH coupling constants in 15N-labeled proteins , 1990 .

[16]  Mark G. Bures,et al.  Using three-dimensional substructure searching to identify novel, non-peptidic inhibitors of HIV-1 protease , 1990 .

[17]  A. Petros,et al.  Conformation of two non‐immunosuppressive FK506 analogs when bound to FKBP by isotope‐filtered NMR , 1992, FEBS letters.

[18]  A. Gronenborn,et al.  Solution structure of a calmodulin-target peptide complex by multidimensional NMR. , 1994, Science.

[19]  A. Petros,et al.  NMR studies of an FK-506 analogue, [U-13C]ascomycin, bound to FKBP: conformation and regions of ascomycin involved in binding. , 1991, Journal of medicinal chemistry.

[20]  J J Baldwin,et al.  Carbonic anhydrase inhibitors for the treatment of glaucoma , 2023, Медицинская этика.

[21]  L. Mueller,et al.  NMR identification of protein surfaces using paramagnetic probes. , 1990, Biochemistry.

[22]  K. Wüthrich,et al.  Heteronuclear filters in two-dimensional [1H, 1H]-NMR spectroscopy: combined use with isotope labelling for studies of macromolecular conformation and intermolecular interactions , 1990, Quarterly Reviews of Biophysics.

[23]  S. Fesik,et al.  NMR studies of molecular complexes as a tool in drug design. , 1991, Journal of medicinal chemistry.

[24]  E. Olejniczak,et al.  NMR methods for determining the structures of enzyme/inhibitor complexes as an aid in drug design. , 1990, Biochemical pharmacology.

[25]  S. Fesik,et al.  Isotope-edited proton NMR study on the structure of a pepsin/inhibitor complex. , 1988, Biochemistry.

[26]  M Karplus,et al.  Solution structure of FKBP, a rotamase enzyme and receptor for FK506 and rapamycin , 1991, Science.

[27]  W. Howe,et al.  Computer design of bioactive molecules: A method for receptor‐based de novo ligand design , 1991, Proteins.

[28]  P L Weber,et al.  Determining stereo-specific 1H nuclear magnetic resonance assignments from distance geometry calculations. , 1988, Journal of molecular biology.

[29]  J. Anglister,et al.  Magnetic resonance of a monoclonal anti-spin-label antibody , 1984 .

[30]  D. Doddrell,et al.  NMR OF PROTONS COUPLED TO CARBON-13 NUCLEI ONLY , 1981 .

[31]  A M Gronenborn,et al.  Four-dimensional heteronuclear triple-resonance NMR spectroscopy of interleukin-1 beta in solution. , 1990, Science.

[32]  Stephen W. Fesik,et al.  Stereospecific assignments and χ1 rotamers for FKBP when bound to ascomycin from 3 J Hα,Hβ and 3 J N,Hβ coupling constants , 1992 .

[33]  A. Gronenborn,et al.  Theory and applications of the transferred nuclear overhauser effect to the study of the conformations of small ligands bound to proteins , 1982 .

[34]  W. C. Still,et al.  Semianalytical treatment of solvation for molecular mechanics and dynamics , 1990 .

[35]  D. Egan,et al.  NMR studies of [U-13C]cyclosporin A bound to cyclophilin: bound conformation and portions of cyclosporin involved in binding. , 1994, Biochemistry.

[36]  A. Petros,et al.  Identification of solvent-exposed regions of enzyme-bound ligands by nuclear magnetic resonance , 1991 .

[37]  Robert P. Sheridan,et al.  3DSEARCH: a system for three-dimensional substructure searching , 1989, J. Chem. Inf. Comput. Sci..

[38]  D. E. Anderson,et al.  Expression and nitrogen-15 labeling of proteins for proton and nitrogen-15 nuclear magnetic resonance. , 1989, Methods in enzymology.

[39]  Yvonne C. Martin,et al.  ALADDIN: An integrated tool for computer-assisted molecular design and pharmacophore recognition from geometric, steric, and substructure searching of three-dimensional molecular structures , 1989, J. Comput. Aided Mol. Des..

[40]  A M Gronenborn,et al.  Structures of larger proteins in solution: three- and four-dimensional heteronuclear NMR spectroscopy. , 1991, Science.

[41]  A. Petros,et al.  Four-dimensional [13C,1H,13C,1H] HMQC-NOE-HMQC NMR spectroscopy: resolving tertiary nuclear Overhauser effect distance constraints in the spectra of larger proteins , 1991 .

[42]  N. W. Murrall,et al.  Conformational freedom in 3-D databases. 1. Techniques , 1990, J. Chem. Inf. Comput. Sci..

[43]  J. Feeney,et al.  The use of transferred nuclear Overhauser effects in the study of the conformations of small molecules bound to proteins , 1979 .

[44]  A. Petros,et al.  NMR studies of an FK-506 analog, [U-13C]ascomycin, bound to FK-506-binding protein. , 1992, Journal of medicinal chemistry.

[45]  P. Goodford.  A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.

[46]  R. Griffey,et al.  Proton-detected heteronuclear edited and correlated nuclear magnetic resonance and nuclear Overhauser effect in solution , 1987, Quarterly Reviews of Biophysics.

[47]  C. Hilbers,et al.  Mapping of ligand binding sites on macromolecules by means of spin-labeled ligands and 2D difference spectroscopy , 1988 .

[48]  D. Egan,et al.  Isotope-edited NMR of cyclosporin A bound to cyclophilin: evidence for a trans 9,10 amide bond. , 1990, Science.

[49]  G. Wider,et al.  Use of a double half-filter in two-dimensional proton NMR studies of receptor-bound cyclosporin , 1990 .

[50]  Y. Thériault,et al.  Solution structure of the cyclosporin A/cyclophilin complex by NMR , 1993, Nature.

[51]  I. Kuntz,et al.  Structure-based design of nonpeptide inhibitors specific for the human immunodeficiency virus 1 protease. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Hans-Joachim Böhm,et al.  The computer program LUDI: A new method for the de novo design of enzyme inhibitors , 1992, J. Comput. Aided Mol. Des..

[53]  M. Fitzgibbon,et al.  Solution structure of the major binding protein for the immunosuppressant FK506 , 1991, Nature.

[54]  A. Bax,et al.  Simplification of two-dimensional NOE spectra of proteins by 13C labeling , 1987 .

[55]  K Wüthrich,et al.  The NMR structure of cyclosporin A bound to cyclophilin in aqueous solution. , 1991, Biochemistry.

[56]  Ronald Breslow,et al.  Molecular recognition , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[57]  A. Petros,et al.  A practical method for uniform isotopic labeling of recombinant proteins in mammalian cells. , 1992, Biochemistry.

[58]  J M Blaney,et al.  A geometric approach to macromolecule-ligand interactions. , 1982, Journal of molecular biology.

[59]  Y. Martin,et al.  3D database searching in drug design. , 1992, Journal of medicinal chemistry.

[60]  K. Wüthrich,et al.  Editing of 2D 1H NMR spectra using X half-filters. combined use with residue-selective 15N labeling of proteins , 1986 .

[61]  A. Gronenborn,et al.  Transfer-of-saturation NMR studies of protein-ligand complexes. Three-site exchange , 1981 .

[62]  G. Montelione,et al.  Accurate measurements of proton scalar coupling constants using carbon-13 isotropic mixing spectroscopy , 1992 .

[63]  L. Kay,et al.  Four-dimensional carbon-13/carbon-13-edited nuclear Overhauser enhancement spectroscopy of a protein in solution: application to interleukin 1.beta. , 1991 .

[64]  Akiko Itai,et al.  Automatic creation of drug candidate structures based on receptor structure. Starting point for artificial lead generation , 1991 .

[65]  A. Petros,et al.  Three-dimensional structure of the FK506 binding protein/ascomycin complex in solution by heteronuclear three- and four-dimensional NMR. , 1993, Biochemistry.

[66]  Ad Bax,et al.  Isotope-filtered 2D NMR of a protein-peptide complex: study of a skeletal muscle myosin light chain kinase fragment bound to calmodulin , 1992 .

[67]  P. Wright,et al.  Site-selective observation of nuclear Overhauser effects in proteins via isotopic labeling , 1987 .